Bayer-Natco Stivarga Infringement Case Simmers In India
Executive Summary
Bayer is battling Natco in another high-profile infringement suit in India, this time pertaining to its anticancer Stivarga (regorafenib). The case has many legs and is to be re-heard by a single judge on the orders of a division bench.